SUPPLEMENTARY PROSPECTUS APPROVAL
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA, SINGAPORE, HONG KONG OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.
This announcement does not constitute and may not be construed as, an offer to sell or an invitation to purchase, investments of any description, a recommendation regarding the issue or the provision of investment advice by any party. No information set out in this announcement or referred to in other written or oral form is intended to form the basis of any contract of sale, investment decision or any decision to purchase shares in the Company.
Further to the announcement on 24 August 2016, InnovaDerma PLC (the “Company”) has today published a Supplementary Prospectus approved by the UK Listing Authority which is supplementary to and must be read in conjunction with the Prospectus of the Company which was published on 25 July 2016.
A copy of the Supplementary Prospectus will be available for inspection at the National Storage Mechanism which is located at www.morningstar.co.uk/uk/NSM. Copies of the Supplementary Prospectus will also be available on the Company’s website, www.innovaderma.com, and in printed form free of charge at the registered office of the Company until 14 days after Admission.
Haris Chaudhry/Joe Bayer
|+61 (0)3 9111 0071|
Claire Noyce/Niall Pearson
|+44 (0)203 764 2341 / 2343|
Shan Shan Willenbrock
|+44 (0)20 7930 0777|
InnovaDerma PLC specialises in the research, manufacture and marketing of clinically proven products in hair loss, anti-ageing and beauty sectors. InnovaDerma has presence in the United Kingdom, Australia, New Zealand, Philippines, South Africa, Hong Kong and South Korea.